Essential Thrombocythemia

This is a condition where you have too many platelets in your blood. Platelets help stop bleeding, so having too many can increase your risk of bleeding or bruising. It's called 'essential' because the exact cause isn't always clear.

Condition

What people with Essential Thrombocythemia report

Every report comes from a Lived member, sent anonymously.

Have you tried Hydroxyurea for Essential Thrombocythemia?

NameHow it went

About Essential Thrombocythemia

What It Is

Essential thrombocythemia (ET) is a long-term bone marrow disorder in which the marrow makes too many platelets, the small blood cells that clump together to stop bleeding. With far more platelets in circulation, and platelets that do not always work normally, blood clots can form inside blood vessels where they are not needed. Less often, people with very high counts bleed more easily. ET belongs to a group of slow-growing blood cancers called myeloproliferative neoplasms, which also includes polycythemia vera and myelofibrosis. Most people feel well when it is found, often by chance on a routine blood count. When symptoms occur, they usually come from sluggish flow in small vessels: headaches, dizziness, visual disturbances, or burning, red and painful hands and feet (a symptom called erythromelalgia). The main concern is the risk of a clot in an artery or vein, which can cause a stroke, heart attack or a clot in the leg or lung. ET is different from the much more common reactive (secondary) thrombocytosis, in which platelets rise because of something else, such as iron deficiency, an infection or inflammation. Reactive thrombocytosis carries less clot risk and is managed by treating its cause.

Causes & Risk Factors

ET starts when a bone marrow stem cell acquires a gene change that keeps the signals for platelet production switched on. These changes develop during a person's life and are not usually inherited. A little over half of people with ET have a change in a gene called JAK2, about one in five has a change in a gene called CALR, a small number have a change in a third gene, MPL, and in roughly one in five no driver mutation is found. Very rarely, ET-like high platelet counts run in families because of an inherited gene change. No lifestyle habit or exposure is known to cause ET. It is most often diagnosed between ages 50 and 70, though it can appear at any age, and it is more common in women. Other factors shape the risk of complications rather than the disease itself. Clots are more likely in people over 60, people who have already had a clot, and people with a JAK2 change. Smoking, diabetes and high blood pressure add to that risk.

How It's Diagnosed

ET is usually suspected when a complete blood count shows a platelet count of about 450,000 per microliter of blood or higher. A high count alone is not enough, because many common problems raise platelets temporarily. The first step is ruling those out: iron deficiency, infection, inflammatory conditions, recent surgery or blood loss, removal of the spleen, and some cancers. A hematologist (a blood specialist) then looks for signs that the marrow itself is the source. A blood test for JAK2, CALR and MPL gene changes supports the diagnosis when positive, though a negative result does not rule ET out. A bone marrow biopsy, in which a small sample of marrow is taken with a needle, shows whether the cells that make platelets are increased and helps separate ET from look-alike conditions such as early myelofibrosis, polycythemia vera and chronic myeloid leukemia. That distinction matters because those conditions follow a different course. Once ET is confirmed, the specialist estimates clot risk from age, past clots and the JAK2 result. This risk level, more than the platelet number itself, guides treatment.

Treatment Options

There is no cure for ET, but treatment can substantially lower the chance of clots and control symptoms. The plan depends on clot risk, and some people need little more than regular monitoring. Low-dose aspirin is used for many people to make platelets less sticky, and it often relieves burning hands and feet and headaches quickly. It is not automatic. Its protection against major clots in ET rests on observational studies rather than trials, and it can increase bleeding. Doctors often avoid routine aspirin in lower-risk people with a CALR change or a platelet count above about 1,000,000, where bleeding becomes more of a concern. People at high risk, meaning those who have had a clot or are over 60 with a JAK2 change, are usually offered a medicine that lowers the platelet count as well. Hydroxyurea, an oral medicine that slows blood cell production, is the most common choice; it needs regular blood counts and should not be taken during pregnancy. Ropeginterferon alfa-2b (Besremi), a long-acting interferon given as an injection under the skin, is approved in the US for adults with ET; it can cause flu-like symptoms and, less often, serious mood, autoimmune or infection problems, so it needs close monitoring. Anagrelide (Agrylin), a capsule that specifically lowers platelets, is usually reserved for people who cannot take or do not respond to the others, because it can cause palpitations and other heart effects. Controlling smoking, blood pressure, diabetes and cholesterol is part of treatment, because these add to the clot risk ET already carries.

What to Expect

ET usually progresses slowly, and many people live for decades with it. Day to day, most feel well, and life with ET mostly means taking a daily medicine if one is prescribed and having blood counts checked, every few weeks when starting a platelet-lowering drug and less often once stable. On average, life expectancy is somewhat shorter than in the general population, with the difference larger in people diagnosed at older ages. Over many years, a small number of people develop myelofibrosis (scarring of the bone marrow) or, more rarely, acute leukemia. Follow-up visits look for clues such as a falling red blood cell count or an enlarging spleen, so a change can be recognized early. Some situations need extra planning. Surgery and dental procedures may require adjusting aspirin or other medicines beforehand. Pregnancy is possible with ET but carries a higher risk of complications, and some treatments can harm a developing baby, so anyone who could become pregnant should plan with the hematologist ahead of time.

When to Seek Help

See a doctor if a routine blood test shows a high platelet count, or if you have frequent headaches, dizziness, visual disturbances or burning, red hands and feet, so the cause can be checked. If you have ET, contact your care team promptly about nosebleeds, bleeding gums, easy bruising, black or bloody stools, or a swollen, painful leg, and about new side effects from treatment. Call 911 for sudden weakness or numbness on one side of the body, trouble speaking, sudden loss of vision, chest pain, or sudden shortness of breath, which can signal a stroke, heart attack or a clot in the lung.

Questions to Ask Your Doctor

  1. 1.What is my risk of a blood clot, and which factors, such as my age or gene result, drive it?
  2. 2.Do the benefits of aspirin outweigh the bleeding risk for me?
  3. 3.Do I need a medicine to lower my platelet count, and how will we decide between hydroxyurea, interferon and anagrelide?
  4. 4.How often will my blood be checked, and what changes would make us revisit the plan?
  5. 5.What should I plan for before surgery, dental work or a pregnancy?

Last reviewed • Oct 2026

Educational content, not medical advice.